Literature DB >> 10328661

The pathogenesis of periodontal diseases.

.   

Abstract

This informational paper was prepared by the Research, Science, and Therapy Committee of The American Academy of Periodontology, and is intended for the information of the dental profession. The purpose of the paper is to provide an overview of current knowledge relating to the pathogenesis of periodontal diseases. The paper will review biological processes thought to provide protection against periodontal infections. It will further discuss the mechanisms thought to be responsible for both overcoming and subverting such protective mechanisms and those that lead to destruction of periodontal tissues. Since an understanding of pathogenic mechanisms of disease is one foundation upon which new diagnostic and therapeutic modalities are based, the practitioner can use this information to help make decisions regarding the appropriate application of such new modalities in patient care settings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328661     DOI: 10.1902/jop.1999.70.4.457

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  34 in total

1.  Long-term effect of heat shock protein 60 from Actinobacillus actinomycetemcomitans on epithelial cell viability and mitogen-activated protein kinases.

Authors:  Liangxuan Zhang; Steven Pelech; Veli-Jukka Uitto
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion.

Authors:  A Lourbakos; J Potempa; J Travis; M R D'Andrea; P Andrade-Gordon; R Santulli; E J Mackie; R N Pike
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.

Authors:  G N Belibasakis; A Johansson; Y Wang; C Chen; S Kalfas; U H Lerner
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 4.  Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Authors:  Ali Cekici; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

5.  Effect of periodontal therapy on salivary interleukin-12 levels in chronic periodontitis.

Authors:  Anamika Sharma; B P Khattak; S Naagtilak; Ganesh Singh; Tanveer Bano
Journal:  J Clin Diagn Res       Date:  2014-10-20

6.  Design of a protocol for obtaining genomic DNA from saliva using mouthwash: Samples taken from patients with periodontal disease.

Authors:  Ángel Chávez Mendoza; Beatriz Buentello Volante; María Esther Ocharán Hernández; Claudia Camelia Calzada Mendoza; Arturo Flores Pliego; Héctor A Baptista Gonzalez; Higinio Estrada Juárez
Journal:  J Oral Biol Craniofac Res       Date:  2016-02-11

7.  Cultivable oral microbiota of domestic dogs.

Authors:  David R Elliott; Michael Wilson; Catherine M F Buckley; David A Spratt
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

8.  The effect of photobiomodulation therapy on nonsurgical periodontal treatment in patients with type 2 diabetes mellitus: a randomized controlled, single-blind, split-mouth clinical trial.

Authors:  Seda Sevinç Özberk; Hasan Gündoğar; Mesut Özkaya; İbrahim Levent Taner; Kamile Erciyas
Journal:  Lasers Med Sci       Date:  2019-10-23       Impact factor: 3.161

9.  Anti-HMGB1 Neutralizing Antibody Attenuates Periodontal Inflammation and Bone Resorption in a Murine Periodontitis Model.

Authors:  Chiaki Yoshihara-Hirata; Keisuke Yamashiro; Tadashi Yamamoto; Hiroaki Aoyagi; Hidetaka Ideguchi; Mari Kawamura; Risa Suzuki; Mitsuaki Ono; Hidenori Wake; Masahiro Nishibori; Shogo Takashiba
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

Review 10.  Periodontal disease and diabetes mellitus.

Authors:  Jeffery Pucher; James Stewart
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.